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Recessive nephrocerebellar syndrome on the
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We describe a novel nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum among 30 children (ages 1.0 to 28
years) from diverse Amish demes. Children with nephrocerebellar syndrome had progressive microcephaly, visual impairment,
stagnant psychomotor development, abnormal extrapyramidal movements and nephrosis. Fourteen died between ages 2.7 and 28
years, typically from renal failure. Post-mortem studies revealed (i) micrencephaly without polymicrogyria or heterotopia;
(ii) atrophic cerebellar hemispheres with stunted folia, profound granule cell depletion, Bergmann gliosis, and signs of Purkinje
cell deafferentation; (iii) selective striatal cholinergic interneuron loss; and (iv) optic atrophy with delamination of the lateral
geniculate nuclei. Renal tissue showed focal and segmental glomerulosclerosis and extensive effacement and microvillus transform-
ation of podocyte foot processes. Nephrocerebellar syndrome mapped to 700 kb on chromosome 15, which contained a single
novel homozygous frameshift variant (WDR73 c.888delT; p.Phe296Leufs*26). WDR73 protein is expressed in human cerebral
cortex, hippocampus, and cultured embryonic kidney cells. It is concentrated at mitotic microtubules and interacts with a-, b-, and
-tubulin, heat shock proteins 70 and 90 (HSP-70; HSP-90), and the carbamoyl phosphate synthetase 2/aspartate transcarbamy-
lase/dihydroorotase multi-enzyme complex. Recombinant WDR73 p.Phe296Leufs*26 and p.Arg256Profs*18 proteins are trun-
cated, unstable, and show increased interaction with a- and b-tubulin and HSP-70/HSP-90. Fibroblasts from patients homozygous
for WDR73 p.Phe296Leufs*26 proliferate poorly in primary culture and senesce early. Our data suggest that in humans, WDR73
interacts with mitotic microtubules to regulate cell cycle progression, proliferation and survival in brain and kidney. We extend the
Galloway-Mowat syndrome spectrum with the ﬁrst description of diencephalic and striatal neuropathology.
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Introduction
We identiﬁed 27 children from six different North
American Amish demes who exhibited a nephrocerebellar
syndrome (NCS) on the Galloway-Mowat spectrum
(OMIM 251300) (Galloway and Mowat, 1968; Cohen
and Turner, 1994; Sano et al., 1995; Meyers et al., 1999;
Steiss et al., 2005; Keith et al., 2011; Ekstrand et al., 2012;
Colin et al., 2014) characterized by progressive microceph-
aly, cortical visual impairment with congenital roving
nystagmus, arrested psychomotor development, an extra-
pyramidal movement disorder, and steroid non-responsive
progressive renal failure. Autozygosity mapping identiﬁed a
700 kb homozygous haplotype block on chromosome 15
shared among affected children, which we queried with
exome sequencing. A single novel protein-truncating frame-
shift variant (WDR73 c.888delT; p.Phe296Leufs*26) was
homozygous in all affected children and heterozygous in
parents. An additional 800 children with inherited neph-
rotic syndrome of unknown genetic cause were then
screened with microﬂuidic multiplex PCR (Fluidigm) and
next-generation sequencing (Halbritter et al., 2012;
Sadowski et al., 2015) (Boston Children’s Hospital), and
a second homozygous frameshift variant (WDR73
c.766dupC; p.Arg256Profs*18) was identiﬁed in a child
with NCS from Bulgaria. The latter variant was also re-
cently associated with NCS on the Galloway-Mowat syn-
drome spectrum (characterized as ‘late-onset Galloway-
Mowat syndrome’) in an unrelated Turkish child (Colin
et al., 2014).
Colin et al. (2014) associated two recessive loss-
of-function mutations in WDR73 (c.129T4G; p.Tyr43*
and c.766dupC) with late-onset Galloway-Mowat syn-
drome in three affected children and provided a detailed
description of the associated kidney pathology. WDR73 is
a WD repeat (WDR) protein that is expressed in the
embryonic brain and kidneys and associates with the
mitotic microtubules during cell division (Colin et al.,
2014). WDR proteins participate in diverse cellular func-
tions, including cell division, signal transduction, vesicle
trafﬁcking, cytoskeletal dynamics, DNA excision repair,
nuclear envelope transport, and autophagy (van Nocker
and Ludwig, 2003; Huebner et al., 2004; Meyer, 2007;
Storr et al., 2009; Haack et al., 2012; Saijo, 2013; Colin
et al., 2014), and several have been linked to developmen-
tal disorders (e.g. WDR45, WDR62, WDR81, PAFAH1B1,
ERCC8 and AAAS) (Supplementary Table 1) (Gambello
et al., 2003; Huebner et al., 2004; Bilguvar et al., 2010;
Gulsuner et al., 2011; Haack et al., 2012; Baez et al.,
2013).
Here we associate a novel protein-truncating mutation in
WDR73 with a nephrocerebellar syndrome on the
Galloway-Mowat syndrome spectrum (herein referred to
as NCS) characterized by abnormal cerebral cortical
growth without polymicrogyria or heterotopia, cerebellar
hypoplasia with granule layer aplasia, aberrant visual
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pathway development, depletion of striatal cholinergic
interneurons, and focal segmental glomerulosclerosis.
Our studies of the WDR73 interactome demonstrate that
WDR73 interacts with proteins vital to cell cycle and sur-
vival, including -(TUBA1B), b-(TUBB4B), and -
(TUBG1) tubulin, HSP-70 (HSPA1A/HSPA1B), HSP-90
(HSP90AA1), p70S6 kinase (RPS6KB1), and CAD (CAD;
carbamoyl-phosphate synthetase 2, aspartate transcarbamy-
lase, and dihydroorotase), a mTORC1-regulated multi-
enzyme complex that mediates de novo pyrimidine synthe-
sis (Ben-Sahra et al., 2013; Robitaille et al., 2013). In vitro,
recombinant pathogenic WDR73 variants have increased
interactions with - and b-tubulin and HSP-90.
Fibroblasts from affected children have a cell cycle disrup-
tion that substantially slows division, alters the interphase
microtubule network and cell morphology, and accelerates
senescence. The cell cycle defect can be rescued with wild-
type WDR73. Our detailed neuropathological analysis dif-
ferentiates WDR73-associated NCS from other forms of
Galloway-Mowat syndrome and extends the clinical patho-
logical spectrum. Our observations together with those of
Colin et al. (2014) support a critical role for WDR73 in the
proliferation and survival of human brain and kidney cells.
Materials and methods
Patients
The study was approved by Institutional Review Boards of
Lancaster General Hospital, Boston Children’s Hospital, the
University of Arizona, the University of Exeter, the DDC
Clinic for Special Needs Children, and the Broad Institute.
Parents consented on behalf of their children. Thirty patients
with NCS (mean age 9.2 years, range 1.4 to 28 years) origi-
nated from three different endogamous Old Order Amish
demes and hailed from six states: Pennsylvania, Ohio,
Indiana, Michigan, Colorado and Montana. A Bulgarian
child with NCS [5 years old at time of diagnosis and unrelated
to the WDR73 c.766dupC patient described by Colin et al.
(2014)] was added to the study through additional screening at
Boston Children’s Hospital (see below).
Genetic mapping
Genetic mapping was conducted as previously described
(Puffenberger et al., 2004). Genotyping was performed using
GeneChip Mapping 10K and 50K Assay Kits (Affymetrix)
and single nucleotide polymorphism (SNP) data were analysed
using Microsoft Excel. Genotype data came from Affymetrix
GeneChip Human Mapping 10K Xba 142 and 50K Xba
Arrays and SNP positions came from Affymetrix genome
annotation ﬁles. Genotype data from multiple affected individ-
uals were examined for shared blocks of homozygosity assum-
ing mutation and locus homogeneity. SNP data from 100
healthy Old Order Amish females were used to estimate popu-
lation-speciﬁc allele frequencies. Two-point LOD scores
[logarithm (base 10) of odds] were calculated for each SNP
using an approach similar to Broman and Weber (1999). For
each block of shared homozygous SNPs, we calculated a
cumulative two-point LOD score (‘location score’) (Broman
and Weber, 1999) that indicated the relative probability that
the disease gene resided in the homozygous block.
Exome sequencing
Exome sequencing was performed at the Broad Institute using
the Agilent SureSelect All Exon Kit (v.1, 38Mb) as previously
described (Puffenberger et al., 2012).
Neuropathology
In Case 1, the ﬁxed brain was ﬁrst examined macroscopically,
and then microscopically using multiple parafﬁn embedded
blocks. In Case 2, a limited number of parafﬁn blocks were
received from the NICHD Brain and Tissue Bank for
Developmental Disorders at the University of Maryland.
Standard histological and immunohistological methods
were used as described previously (Harding et al., 2015)
with the addition of immunocytochemistry for choline acetyl-
transferase (Chat22 goat polyclonal antibody 1:100, #AB144P,
Millipore).
WDR73 expression in human brain:
tissue processing and
immunohistochemistry
Frontal neocortex and cerebellar specimens were obtained
from three control subjects who died of non-neurological
causes (mean age 5.8 years; two male, one female; Brain and
Tissue Bank for Developmental Disorders, University of
Maryland, mean post-mortem interval = 14 h, range 11–16 h).
Cortical cytoarchitecture of specimens was intact. Human
tissue specimens were either ﬁxed in 4% paraformaldehyde
and parafﬁn embedded or ﬂash frozen at 70C. Tissue
blocks were microtome sectioned at 7 mm and ﬁve representa-
tive sections per case were probed with WDR73 antibodies
(Novus Biologicals, rabbit polyclonal, 1:200) overnight at
4C. Sections were then probed with biotinylated secondary
antibodies for 1 h at room temperature and visualized
using avidin-biotin conjugation (Vectastain ABC Elite;
Vector Labs) with 3,3’-diaminobenzidine. Dehydrated sections
were mounted with coverslips (Permount). Light-
microscopy images were acquired using a Leica DM4000 B
microscope. All human tissue was obtained using protocols
approved by the Temple University Institutional Review
Board.
Renal pathology
Tissue was processed by standard methods for light micros-
copy, direct immunoﬂuorescence, and electron microscopy. All
materials were examined by a renal pathologist (A.F.), and an
integrated diagnosis was rendered.
Cell culture
Primary cultures of dermal ﬁbroblasts from NCS subjects
(homozygous c.888delT) and their heterozygous parents
were established by the Coriell Institute (Camden, NJ), and
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normal human dermal ﬁbroblasts (NHDFs) were purchased
from Coriell. Fibroblasts and HEK-293T cells (ATCC) were
cultured at low passage (410) in Dulbecco’s modiﬁed Eagle
medium (DMEM) (Life Technologies) with 10% foetal bovine
serum (FBS) at 37C and 5% CO2. Mouse neural progenitor
cells were derived from the subventricular zone of C57BL/6
postnatal Day 1 mice as described previously (Orlova et al.,
2010). Mouse neural progenitor cells were cultured on poly-D-
lysine coated plates in DMEM/F12 with 1% FBS, 1% N-2
supplement, 1% penicillin/streptomycin, ﬁbroblast growth
factor, and heparin and maintained at 37C. Human astro-
cytes were obtained from resected temporal lobe epilepsy spe-
cimens (courtesy D. Kolson M.D., Ph.D., University of
Pennsylvania). For immunoblotting shown in Fig. 4 and im-
munoﬂuorescence shown in Supplementary Fig. 2, NHDFs and
astrocytes were grown in DMEM (Life Technologies #11962-
084), 5% FBS, 1% penicillin/streptomycin, 5ml per 500ml
total volume of AGS solution (from ScienCell, cat # 1852).
U87 glioma lines were obtained (courtesy D. O’Rorke M.D.,
Ph.D., University of Pennsylvania) and maintained in DMEM
(Life Technologies, #11965-084, 10% FBS, 1% penicillin/
streptomycin). Human neural stem cells (H-9 derived, Life
Technologies; cat #10142-01) were grown and maintained in
StemPro NSC medium (KnockOut DMEM/F-12,
GlutaMAXTM supplement, bFGF, EGF, and StemPro Neural
Supplement, #A10508-0) at 37C and 5% CO2.
Cell proliferation assay
Dermal ﬁbroblasts seeded at equal densities on 6- or 12-well
plates in DMEM with 10% FBS were cultured (medium
replaced every 2–3 days) until NHDFs reached conﬂuency
(Fig. 4) or until heterozygous parent cells reached 50–75%
conﬂuency (Supplementary Fig. 1). Cells were then washed
with phosphate-buffered saline (PBS; pH 7.2), ﬁxed for
15min with 4% paraformaldehyde in PBS at 21C, washed
with sterile water, stained with 0.1% crystal violet in 10%
ethanol for 20min, and washed three times with sterile
water. Plates were dried and scanned on an Epson ﬂatbed
scanner. Cells were then extracted with 10% acetic acid and
the absorbance of the extract was measured with a spectro-
photometer at 590 nm. Data were analysed using Student’s
t-test ( = 0.05) with Microsoft Excel.
Immunofluorescence microscopy
Fibroblasts and HEK-293T cells cultured on uncoated German
glass coverslips were rinsed with PBS at 37C and ﬁxed with
4% paraformaldehyde at 21C for 15min. Cells were then
prepared for immunoﬂuorescence microscopy and documented
as described previously (Puffenberger et al., 2012) using the
following primary antibodies: anti-WDR73 (1:50) [Sigma
HPA039357 rabbit polyclonal; same as Novus NBP1-82219;
validated by short hairpin (sh)RNA knockdown of WDR73
and overexpression of recombinant WDR73 in HEK-293T
cells; Figs 6C–E and 7E]; anti-WDR73 (1:50) (Thermo PA5-
25221 rabbit polyclonal; validated against overexpression of
WDR73; Fig. 6C–E); anti--tubulin (1:1500) (Sigma T6074);
anti-b-actin (1:200) (Sigma A1978); anti-V5 (1:500) (Life
Technologies 377500). Secondary antibodies: Alexa Fluor
488- (green) or 594- (red) conjugated goat anti-rabbit or
mouse IgG (1:400) (Life Technologies). For Supplementary
Fig. 2, cells were ﬁxed in ice-cold 4% paraformaldehyde
and probed with WDR73 antibodies (Novus NBP1-82219)
overnight at 0C and then with Texas Red or FITC conju-
gated anti-rabbit IgG secondary antibody. Coverslips were
mounted with Fluoromount-GTM (Electron Microscopy
Sciences). To synchronize ﬁbroblasts in mitosis, double-
thymidine block was performed as described previously
(Robitaille et al., 2013). All experiments were replicated two
to ﬁve times.
MitoTracker Red was used to label the mitochondrial net-
work. Brieﬂy, cells were incubated with MitoTracker Red
CMXRos (300 nM) at 37C/5% CO2 for 30min, washed
with PBS, and ﬁxed in 4% paraformaldehyde in PBS for
15min at 37C. Cells were then permeabilized in acetone at
20C for 5min, washed with PBS, and counterstained with
DAPI (4’,6-diamidino-2-phenylindole; 1.5 mg/ml; Santa Cruz
Biotechnology).
Co-immunoprecipitation and
immunoblotting
Frozen human tissues (cortex and cerebellum) and cell lines
(Figs 4A, 7E, and Supplementary Fig. 4E) were lysed in
RIPA buffer (50mM Tris HCl pH 8.0; 150mM NaCl; 1%
NP-40; 0.5% sodium deoxycholate, 0.1% SDS, protease and
phosphatase inhibitors). Protein (30 mg) was separated on
4–15% SDS-PAGE Tris-Glycine gels (Bio-Rad), transferred
onto PVDF membranes and probed with anti-WDR 73 anti-
bodies (Novus; 1:1000) overnight at 4C and horseradish per-
oxidase-conjugated secondary antibodies (GE Healthcare) for
1 h at room temperature, and visualized with ECL or ECL Plus
(GE Healthcare). Anti-GAPDH (Cell Signaling) labelling was
used to ensure equal protein loading. Each set of experiments
was repeated twice. For the remaining ﬁgures, cells were lysed
in ice-cold RIPA or CelLytic M (Sigma) lysis buffer with pro-
tease and phosphatase inhibitor cocktail (Roche) and 1mM
phenylmethanesulfonylﬂuoride (PMSF; Sigma), separated by
SDS-PAGE on 4–12% Bis-Tris gels (Life Technologies), stained
with Coomassie Brilliant Blue (for mass spectrometry), or
transferred to 0.45 mm nitrocellulose (Bio-Rad). Immunoblots
were prepared and documented as previously described
(Puffenberger et al., 2012) with the following antibodies:
anti-FLAG M2 (1:1000) (Sigma); anti-V5 (1:5000) (Life
Technologies); anti-WDR73 (1:100) (Sigma HPA039357);
anti-b-actin (1:250 000) (Sigma A1978); anti--tubulin
(1:2000) (Sigma T6074); anti--tubulin (1:1000) (Sigma),
anti-COXIV, anti-CAD, anti-phosphoCAD, anti-HSP-70,
anti-HSP-90, anti-p70 S6 kinase, anti-b-tubulin (1:1000)
(Cell Signaling). Immunoblots were stripped and reprobed
using Restore Plus (Thermo) per the manufacturer’s
instructions.
Co-immunoprecipitation assays were performed as described
elsewhere (Puffenberger et al., 2012) with the following excep-
tions: clariﬁed lysates were incubated with the anti-FLAG M2
afﬁnity gel for 2 h at 4C followed by 3–4 15-min washes in
wash buffer with 2.5–5% Tween-20 (Sigma), protease
inhibitors, phosphatase inhibitors, and 1mM PMSF.
Immunoprecipitated proteins were eluted from the afﬁnity gel
with 3 FLAG peptide (150 ng/ml), and immunoblotted as
described above.
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Complementary DNA constructs and
transfection
Human WDR73 (NM_032856.2) and CAD (NM_004341.3)
cDNAs ampliﬁed from HEK-293T total RNA using RT-PCR
(SuperScript III reverse transcriptase, Life Technologies;
Phusion DNA polymerase, NEB) were cloned into pENTR/
D-TOPO (Life Technologies) and mutations indicated in the
‘Results’ section were introduced by site-directed mutagenesis
(QuikChange II, Agilent). Constructs were then recombined
into pCAG/FLAG/RFC-A (Puffenberger et al., 2012) using
LR Clonase II (Life Technologies) for expression of N-
terminal FLAG-tagged fusion proteins. To generate plasmids
for WDR73 and CAD C-terminal V5 fusion proteins, cDNAs
were cloned in-frame directly into pcDNA3.1/TOPO/V5-DEST
or recombined into pcDNA3.2/V5-DEST (Life Technologies).
All constructs were veriﬁed by Sanger sequencing.
HEK-293T cells were transfected with FuGENE6 (Promega)
according to the manufacturer’s protocol and cultured for
40–48 h before immunoﬂuorescence microscopy, immunoblot-
ting, or coimmunoprecipitation. NCS patient ﬁbroblasts were
transfected by nucleofection using the Amaxa Human
Dermal Fibroblast Nucleofector Kit (Lonza) and a
Nucleofector 2b NHDF program optimized for cell viability
following nucleofection.
Results
Genetic mapping
Using 10 000- and 50 000-marker SNP microarrays, we
genotyped ﬁve affected Amish children and identiﬁed a
shared 8.26Mb autozygous block on chromosome 15
that was further reﬁned with nine additional NCS patients
to a 3.96Mb autozygous block (ﬂanked by rs2048271 and
rs959181) that contained 69 genes (Fig. 1C). A single child
from Indiana had a rare recombination event between
rs4359399 and rs713468 that narrowed the minimal auto-
zygous region to 700 kb. Exome sequencing of DNA from
seven children with NCS identiﬁed a novel homozygous
single base pair deletion (WDR73 c.888delT) in all affected
individuals. We used Sanger sequencing to conﬁrm that the
WDR73 c.888delT frameshift was homozygous in all
27 NCS children and heterozygous in parents.
An additional 800 children with idiopathic nephrotic
syndrome were screened using microﬂuidic multiplex PCR
(Fluidigm) and next-generation sequencing (Halbritter
et al., 2012; Sadowski et al., 2015). A second homozy-
gous frameshift variant, WDR73 c.766dupC (p.Arg
256Profs*18) was identiﬁed in a Bulgarian child with
NCS. The WDR73 c.766dupC variant was also identiﬁed
recently in an unrelated child of Turkish descent with NCS
(Colin et al., 2014).
The 3.96Mb Amish autozygous block contained a
second truncating variant in WHAMM (c.1264_
1270delATAAAAG) (NM_001080435.2) on the same
haplotype as the WDR73 mutation. Genotype analysis of
all affected individuals revealed that the Indiana Amish
NCS patient described above (3 years old) was homozy-
gous for only the WDR73 variant, and heterozygous for
the WHAMM mutation. Her clinical course was consistent
with NCS (Fig. 1A) although she had not yet developed
nephrotic syndrome. As kidney disease onset is variable
in NCS/Galloway-Mowat syndrome, this ﬁnding was not
unusual. Three additional affected siblings, not available
for follow-up, were also considered likely to be homozy-
gous for only the WDR73 mutation and wild-type for the
WHAMM mutation (genotypes inferred from parents and
an unaffected sister). We were unable to identify any clin-
ical differences between these three individuals and those
who were doubly homozygous for both WDR73 and
WHAMM variants. In our single non-Amish proband
from Bulgaria, we excluded WHAMM mutations through
Sanger sequencing.
Phenotype of nephrocerebellar
syndrome on the Galloway-Mowat
spectrum
Table 1 summarizes core phenotypic features of 30 NCS
patients (27 conﬁrmed and three inferred WDR73
c.888delT homozygotes) ages 1.4 to 28 years (mean age
9.2 years). Irritability, congenital roving nystagmus, and
visual impairment were early postnatal signs of NCS.
Head growth was slow (Fig. 1A and B) and psychomotor
development was severely delayed in all domains. Affected
children did not effectively communicate or use their hands,
and only 10% achieved independent ambulation (Table 1).
Most children with NCS developed extrapyramidal move-
ments that included a combination of axial dystonia and
limb chorea. Severe visual impairment was associated with
progressive optic atrophy. The majority of affected children
had irregular or reversed sleep-wake patterns.
Multifocal seizures began during infancy or early child-
hood in 41% of affected children. EEGs were characterized
by slow, disorganized background, absent posterior (occipi-
tal) rhythm, poor sleep-wake differentiation, multifocal
sharp and spike-slow wave discharges from various cortical
regions and rarely, high-voltage modiﬁed hypsarrhythmia.
Serial MRIs revealed diffuse cerebral atrophy, thinning of
the corpus callosum, and hypoplasia and progressive atro-
phy of cerebellar tissue (Fig. 1B).
More than half of NCS individuals (57%) developed
steroid non-responsive, ﬂuctuating proteinuria (mean urine
protein:creatinine ratio 12.0mg:mg, range 3.5–20.0mg:mg;
normal reference range 0.0–0.2mg:mg) during early child-
hood (Fig. 3A) in association with pitting oedema, hypoal-
buminaemia, renal insufﬁciency, non-regenerative anaemia,
or some combination of these (Table 1). Among 30 NCS
subjects, 14 (47%) died between ages 2.7 and 28 years
(mean 11.0  8.6 years), in most cases from complications
of renal failure.
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Neuropathology
Brain tissue was examined post-mortem from two affected
females who died from complications of renal failure at ages
3.5 (Case 1) and 9.3 years (Case 2); pathological ﬁndings
were similar. Both brains were small, with ﬁxed weights of
636g (normal for age, 1100g) and 681g (normal for age,
1250g), respectively, and most striking were small sclerotic
cerebella with prominent folia (Fig. 2A and B). The hind-
brain of Case 1 weighed 50 g, only 7.9% of total brain
weight (expected 12%); this was accompanied by ventricular
dilatation, a thin corpus callosum, and atrophic optic nerves
(Fig. 2C and D).
The cerebral cortex showed normal lamination with no
obvious gliosis or cell death. Pathological changes were
found in the visual system, striatum, and cerebellum. Optic
nerve atrophy was conﬁrmed microscopically (Fig. 2C and
D), and both magnocellular and parvocellular neurons of
lateral geniculate nuclei were nearly absent, obliterating the
normal six-layer organization (Fig. 2E and F). No degenera-
tive changes or gliosis were present in the basal ganglia, but
the magnocellular cholinergic interneurons in the striatum
were small and scarce (Fig. 2G and H). By comparison,
medium spiny neurons appeared normal.
The cerebellum in both affected children was markedly
abnormal. Folia of the cerebellar hemispheres and
Figure 1 Nephrocerebellar syndrome. (A) Postnatal brain growth is slow in children with NCS (grey-shaded area = normal head cir-
cumference for age, mean  2 SD; red circles = NCS head circumference, mean  SD). Inset: Children with NCS have no distinctive dysmorphic
features, but the forehead characteristically recedes, reflecting relative hypoplasia of the cerebral cortex; post-mortem brain weights are only
50–60% of normal (photos used with parental permission). (B) MRI at 1.5 T (left to right: axial T2, coronal T2, sagittal T1) shows underdeveloped
frontal lobes (asterisks), thin corpus callosum (yellow arrowheads), and severe atrophy of the cerebellar hemispheres (red arrows) and vermis
(yellow arrows). Comparable images of the same NCS child, taken at 13 months (upper panel) and 32 months (lower panel), reveal progressive
degeneration of cerebellar tissue (arrows). (C) Initial SNP genotyping of five children (inset) mapped recessive NCS to an 8.26 Mb autozygous
block of DNA on chromosome 15 (blue arrow). After the initial mapping, we identified nine additional patients that allowed us to narrow the
shared homozygous interval to 3.96 Mb. Yellow signal indicates the number of contiguous SNPs shared among NCS individuals. For each block of
shared homozygous SNPs, purple signal shows the cumulative two-point LOD score (‘location score’), a relative probability, based on population
allele frequencies, that the disease gene resides in the homozygous block. Subsequent genotyping of all 27 NCS individuals refined the shared locus
to 700 kb, which contained the novel WDR73 c.888delT mutation homozygous in all affected children.
Table 1 Clinical features of 30 individuals with NCS
Mean age in years (range) 9.2 (1.4–28.0)
Neurological phenotype (% affected)
Roving eye movements 100%
Visual impairment/optic atrophy 93%
Non-communicative 97%
No independent ambulation 90%
No independent sitting 90%
Central hypotonia 87%
Extrapyramidal movement disorder 87%
Microcephalya 80%
No purposeful hand use 77%
Epilepsy 41%
Renal phenotype (% affected)
Nephrotic syndromeb 57%
Renal insufficiency/failurec 50%
Untimely deathe 47%
Mean age of death in years (range) 11.0 (2.7–28.0)
Table contains data from 27 confirmed patients and three inferred homozygous
WDR73 c.888delT genotype.
aHead circumference 42 SD below normal for age.
bSeventeen subjects had clinical signs of nephrosis (oedema, ascites) but only 11 had
confirmatory laboratory testing (i.e. serum albumin, urine protein/creatinine ratio).
cFifteen subjects had clinical signs of renal failure (oedema, anemia, oliguria/anuria, etc.)
but only nine had confirmatory laboratory testing (i.e. urea nitrogen, creatinine, etc.).
eIn most cases due to complications of renal failure.
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vermis were short and stubby (Fig. 2I and J) and granule
cells were profoundly depleted (Fig. 2K). Purkinje neuron
morphology was relatively spared but these cells were
decreased in number and crowded together. There was
excessive Bergmann gliosis. The overlying molecular layer
was thin and hypercellular, comprised of Bergmann
glia, misplaced NeuN-positive granule cells, and rare
Purkinje neurons (Fig. 2K). Calbindin and neuroﬁlament
immunostaining of Purkinje neurons revealed spherical den-
dritic swellings covered in ﬁne spikes (‘asteroid bodies’), dys-
morphic dendritic trees forming ‘weeping willow’
arrangements, and occasional Purkinje cell bodies covered in
somal sprouts suggestive of deafferentation (Fig. 2M–O).
Globose (‘torpedo’) swellings of proximal Purkinje cell
axons suggested ongoing cell degeneration (Fig. 2P).
Alpha-tubulin staining revealed occasional binucleate
Purkinje neurons (Supplementary Fig. 1E and F).
Neuroﬁlament staining demonstrated preservation of basket
cells. Dentate nuclei were unaffected (Fig. 2L).
Renal pathology
Renal biopsies in three affected children showed similar
morphological features consistent with primary focal seg-
mental glomerulosclerosis (Fig. 3). Nearly 60% of glomer-
uli exhibited severe sclerosis; remaining glomeruli showed
segmental sclerosis, hyalinosis and adhesion to Bowman’s
capsule. A ‘tram-track’ conﬁguration was occasionally seen
in the glomerular basement membrane (Jones silver stain)
(Fig. 3B). Striped ﬁbrosis with proportional tubular atrophy
Figure 2 Neuropathology of NCS. (A) A child with NCS died from complications of renal failure at 3.5 years of age. Total brain weight was
636 g (60% of expected) and the hindbrain weighed 7.9% of the total (expected 12%). (B) The cerebellum (yellow arrowhead in A) was small, firm
and sclerotic. Luxol Fast Blue (C) and GFAP (D) stains show atrophy and gliosis within cross-sections of the optic nerve. (E) The normal
hexalaminar structure of the lateral geniculate nucleus (LGN) is compared with the lateral geniculate nucleus of an NCS child (F), that is nearly
devoid of magnocellular neurons, parvocellular neurons, and laminae. (G) Choline acetyltransferase staining of normal striatum reveals several
large cholinergic interneurons (arrows), which are absent from a comparable histological section of NCS striatum (H). (I) Normal cerebellar
cortex stained with haematoxylin-eosin is compared to that of NCS cerebellum (J), which has short, stubby folia with sparse nuclei in the granule
cell layer. (K) Higher magnification shows severe depletion of granule cells with relative preservation of Purkinje neurons (arrow) and a thin,
hypercellular molecular layer (ML). (L) Dentate nuclei (arrow) have normal structure and cellularity. (M) Deafferented Purkinje neurons (asterisk)
stained for calbindin and neurofilament have ‘weeping’ dendrite configurations, profusion of dendritic elements into ‘asteroid bodies’ (N) and
other complex branching patterns (O), and (P) bulbous (‘torpedo’) swelling within proximal axons (arrow).
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affected 40–50% of the renal interstitium (Fig. 3C and D).
The glomerular basement membrane (mean 437nm, range
345–686nm) was 3- to 4-fold thicker than normal (average
glomerular basement membrane thickness for age 150nm)
(Fig. 3E). Podocyte foot processes were 80–90% effaced in as-
sociation with extensive microvillus transformation (Fig. 3F).
Expression of WDR73 variants in cells
and tissues
The WDR73 c.888delT variant is predicted to result in
substitution of Phe296 with leucine, followed by 24
frame-shifted amino acids and truncation of full-length
WDR73 from 378 (42 kDa) to 320 (35.1 kDa) amino
acids. WDR73 c.766dupC is predicted to result in a proline
substitution at Arg256, followed by 16 frame-shifted amino
acids and premature termination after amino acid 272,
producing a 29.8 kDa protein (Colin et al., 2014).
Structural homology modelling of full-length WDR73
using WDSPdb/ds (Wang et al., 2015) predicts six beta-
propellar WD repeat domains (Colin et al., 2014).
Phe296, changed to leucine in WDR73 p.Phe296Leufs*26
and deleted in p.Arg256Profs*18, is a protein–protein
interaction hotspot (WDSPdb/ds; Wang et al., 2015) on
Figure 3 Kidney disease. (A) Variable onset of nephrosis is followed by progressive loss of glomerular function, shown as 1/serum creatinine
(dl/mg), in three with NCS who died (red asterisks) from complications of renal failure at ages 3.5, 8, and 12 years. (B) Jones’ stain reveals both
global and segmental sclerosis of glomeruli. (C) ‘Striped’ fibrosis is seen throughout the kidney interstitium. (D) At higher magnification, linear
tracks of fibrosis (arrow) correspond to adjacent tubular atrophy (asterisk). (E) Electron micrographs show a 3- to 4-fold thickening of the
glomerular basement membrane (normal for age, 0.15 mm) accompanied by (F) effacement and microvillus transformation of podocyte foot
processes (arrow).
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the surface of the ﬁfth WD repeat. This suggests that pro-
tein–protein interactions are altered by both pathogenic
WDR73 variants.
In post-mortem brain tissue, wild-type WDR73 immu-
noreactivity was observed within pyramidal cells of the
cerebral cortex and hippocampus (Supplementary Fig. 1A
and B), and within Purkinje and granule cell neurons of the
cerebellum (Supplementary Fig. 1C), where it largely loca-
lized to cytoplasm within somatodendritic domains.
Western blot analysis revealed full-length WDR73
(42 kDa) in human cerebral cortex and cerebellum as well
as ﬁbroblasts, astrocytes, and U87 glioma cells (Fig. 4A; see
also Supplementary Fig. 2).
NHDFs express full-length WDR73 (Fig. 4A and B; see also
Colin et al., 2014) whereas ﬁbroblasts cultured from WDR73
p.Phe296Leufs*26 heterozygotes display two WDR73 immu-
noreactive bands (42kDa and 35kDa), each of reduced
abundance relative to the single band observed in NHDFs
(Fig. 4B). We were unable to culture enough NCS proband
(p.Phe296Leufs*26) ﬁbroblasts to reliably detect a WDR73
band by immunoblotting, but would predict reduced abun-
dance of both WDR73 p.Phe296Leufs*26 and p.Arg2
56Profs*18 based on instability of the recombinant versions
of these proteins (Fig. 6F and G).
Cell proliferation assay
Fibroblasts from NCS patients grow poorly in primary cul-
ture, especially if cultured at low density and beyond 2–3
passages. Over a 2-week period, ﬁbroblasts from an NCS
proband (p.Phe296Leufs*26) and her heterozygous father
grew to 16% and 35% of NHDF density, respectively
(n = 4 replicates) (Fig. 4C). If seeded more densely (5000
cells per well in a 12-well plate) and cultured until NHDFs
reached full conﬂuency, NCS proband and heterozygous
parent cells grew to 43.5% and 78% of NHDF density,
respectively (n = 4) (Supplementary Fig. 1G).
Abnormal cell cycle in NCS
fibroblasts
Fibroblasts from NCS probands (p.Phe296Leufs*26) were
substantially larger (up to 280 mm in diameter) than
NHDFs and heterozygous parent ﬁbroblasts (Figs 4D–I
and 5E–H). Using immunoﬂuorescence microscopy, we
always observed NCS proband ﬁbroblasts in interphase;
they did not appear to progress through other phases of
the cell cycle. Cytoplasmic WDR73 immunoreactivity was
weak in these cells and difﬁcult to distinguish from back-
ground (Fig. 5E–H).
Using live-cell phase contrast microscopy, we occasion-
ally identiﬁed large, distorted structures resembling mitotic
proﬁles (data not shown), but none were observed in
normal telophase/cytokinesis. Instead, 24% of proband
cells (n = 125) observed were bi- or multi-nucleate (Figs.
4H and 5E) and another 20% displayed abnormal nuclear
morphology (bi- or multi-lobed nuclei, budding
micronuclei, and nucleoplasmic bridges) (Fig. 5F). In con-
trast, only 19.2% and 5.5% of nuclei were abnormal in
heterozygous parent ﬁbroblasts (n = 104) and NHDFs
(n = 309), respectively. Actin and mitochondrial networks
appeared normal in NCS proband ﬁbroblasts (Fig. 4G–I
and Supplementary Fig. 1H–J, respectively), although
stress ﬁbres were abundant (Fig. 4H).
WDR73 associates with the mitotic
microtubules during cell division
Reduced proliferation and early senescence of NCS pro-
band ﬁbroblasts suggests that WDR73 plays a fundamental
role in the cell cycle. Accordingly, we determined the sub-
cellular localization of WDR73 immunoreactivity across
the cell cycle in NHDFs (Supplementary Fig. 3; see also
Colin et al., 2014) and parent ﬁbroblasts heterozygous
for WDR73 p.Phe296Leufs*26 (Fig. 5). There were no sub-
stantial differences in WDR73 immunoreactivity between
NHDF and heterozygous parent ﬁbroblasts. During inter-
phase, WDR73 immunoreactivity was diffusely cytoplasmic
(Fig. 5A). As cells transitioned into metaphase, WDR73
immunoreactivity associated strongly with -tubulin at the
spindle poles and spindle microtubules (Fig. 5B). During
anaphase, WDR73 localized to spindle poles, kinetochore
microtubules, and interpolar microtubules (Fig. 5C).
During telophase, WDR73 immunoreactivity transitioned
from the spindle poles along the interpolar microtubules
to the central spindle microtubules, to concentrate at the
midbody microtubules apposing the stem body, where cen-
tral spindle microtubules arising from opposite poles of the
cell overlap (Fig. 5D). These results were consistent across
all cells observed in mitosis. As described above, ﬁbroblasts
from patients homozygous for WDR73 p.Phe296Leufs*26
could not be observed in any phase of cell cycle outside of
interphase (Fig. 5E–H).
Transient overexpression of WDR73 wild-type C-ter-
minal V5 fusion protein in ﬁbroblasts from a patient homo-
zygous for WDR73 p.Phe296Leufs*26 rescued the cell
cycle defect. Transfected cells that presumably had not
yet become binucleate were observed in metaphase (Fig.
6A) and telophase (Fig. 6B) within 5 days of transfection.
Mitotic microtubules were only observed in transfected
NCS patient ﬁbroblasts. To validate our ﬁndings, we also
overexpressed WDR73 wild-type C-terminal V5 fusion pro-
tein in HEK-293T cells. Recombinant WDR73-V5 localized
robustly to the cytoplasm during interphase (data not
shown), transitioned to the developing spindle poles and
astral and spindle microtubules during prometaphase and
metaphase (Fig. 6C and D), and was prominent at spindle
poles, interpolar microtubules, and central spindle/midzone
microtubules during anaphase (Fig. 6E).
WDR73 protein–protein interactions
To explore the WDR73 interactome, we immunoprecipi-
tated N-terminal FLAG-WDR73 wild-type (WT) and
Truncating mutations of WDR73 cause NCS BRAIN 2015: 138; 2173–2190 | 2181
Figure 4 WDR73 expression in human brain and NCS cells. (A) Immunoblot of WDR73 expression in: lanes 1 and 2, normal post-
mortem human cerebellum, cerebral cortex; lanes 3–5, cultured human cells as indicated. (B) Immunoblot of WDR73 from NHDFs and dermal
fibroblasts from a heterozygous (WDR73 + /p.Phe296Leufs*26) parent of a child with NCS. Note the additional lower molecular mass band for
the truncated WDR73 in the heterozygous parent’s cell lysate. (C) NCS (p.Phe296Leufs*26) fibroblasts (fs/fs) grow poorly in primary culture. Left:
Crystal violet cell proliferation assay demonstrating reduced proliferation of dermal fibroblasts from a child with NCS (WDR73 fs/fs) relative to
the heterozygous parent’s cells (WDR73 + /fs) and NHDF (WDR73 + / + ) plated at the same density. Right: Quantification of cell proliferation by
absorbance of extracted crystal violet at 590 nm (n = 4) (***P5 0.001). (D–F) Phase contrast comparison of growth characteristics and
morphologies of NHDF (WDR73 + / + ), NCS (p.Phe296Leufs*26; WDR73 fs/fs), and heterozygous parent fibroblasts (p.Phe296Leufs*26;
WDR73 + /fs) seeded at equal densities and grown under the same conditions on the same 6-well plate. (G–I) Anti-b-actin immunofluorescence
microscopy of NHDF (WDR73 + / + ), NCS (p.Phe296Leufs*26; WDR73 fs/fs), and heterozygous parent fibroblasts (p.Phe296Leufs*26; WDR73
+ /fs). Nuclei were counterstained with DAPI. Scale bars: D–F = 140 mm; G–I = 55 mm.
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Figure 5 WDR73 immunoreactivity in fibroblasts from a child with NCS and a heterozygous parent. (A–D) Heterozygous
(WDR73 + /p.Phe296Leufs*26) parent fibroblasts. (A) Anti-WDR73 (green) immunoreactivity is diffuse and cytosolic during interphase (anti--
tubulin, red). (B) WDR73 immunoreactivity localizes to the spindle poles and spindle microtubules during metaphase. (C) WDR73 immunor-
eactivity at the mitotic spindle poles, kinetochore microtubules and central spindle microtubules during anaphase. (D) WDR73 immunoreactivity
localizes to the midbody microtubules apposing the Flemming body (stem body) during telophase. (E–H) WDR73 immunoreactivity is weak and
cytosolic in NCS fibroblasts homozygous for WDR73 p.Phe296Leufs*26. (E and F) Twenty-two per cent of NCS fibroblasts observed were
binucleate and an additional 20% displayed abnormal nuclear morphology (bi-/multi-lobed nuclei, budding micronuclei, or nucleoplasmic bridges).
(G and H) Additional NCS fibroblasts displaying the range of microtubule network morphology observed. Note that the magnifications are
reduced in E–H. Scale bars: A–D = 10 mm; E–F = 50 mm; G–H = 90mm.
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p.Phe296Leufs*26 fusion proteins overexpressed in HEK-
293T cells. We then used Coomassie staining of eluted pro-
teins, separated by SDS-PAGE, to identify co-immunopre-
cipitated proteins unique to FLAG-WDR73 expressing
lysates as compared to those expressing only FLAG-peptide
(‘empty vector’) (Supplementary Fig. 4A). Five unique
bands present in FLAG-WDR73 expressing cells (n = 4 rep-
licates) were excised, digested with trypsin, and subjected to
peptide mass ﬁngerprinting with mass spectrometry
(MALDI-TOF MS; Pennsylvania State University College
of Medicine, Hershey, PA) (Supplementary Fig. 4A). Four
of the ﬁve bands yielded high conﬁdence protein IDs: -
tubulin 1B (TUBA1B), b-tubulin 4B (TUBB4B) (shared
band), heat shock 70-kDa protein 1A/1B (HSP-70, encoded
by HSPA1A and HSPA1B, respectively), heat shock protein
HSP90 alpha isoform 2 (HSP-90), and CAD, the
mTORC1-regulated multi-enzyme complex consisting of
carbamoyl-phosphate synthetase 2, aspartate transcarbamy-
lase, and dihydroorotase (Robitaille et al., 2013).
Interactions between WDR73 and - and b-tubulin were
conﬁrmed by additional co-immunoprecipitation assays,
which showed that FLAG-WDR73 wild-type co-immuno-
precipitated both subunits from HEK-293T lysates (Fig. 7A
and Supplementary Fig. 4B). Surprisingly, FLAG-WDR73
p.Phe296Leufs*26 (n = 20) and p.Arg256Profs*18 (n = 10)
consistently co-immunoprecipitated substantially greater
abundances of - and b-tubulin, despite the reduced abun-
dance of the truncated proteins (Fig. 7A and Supplementary
Fig. 4B). By comparison, WDR73 immunoprecipitated -
tubulin in relative proportion to the FLAG-WDR73 ‘bait’
abundance (n = 6–9 replicates) (Fig. 7B).
WDR73 interaction with CAD was veriﬁed by FLAG-
WDR73 co-immunoprecipitation of recombinant C-
terminal V5 CAD fusion protein co-overexpressed in
HEK-293T cells (n = 4) (Supplementary Fig. 4C), and by
co-immunoprecipitation of endogenous CAD from HEK-
293T cell lysates overexpressing FLAG-WDR73 fusion pro-
teins (n = 7 for wild-type, p.Phe296Leufs*26; n = 6 for
p.Arg256Profs*18) (Fig. 7C). Co-immunoprecipitation of
CAD was not affected by WDR73 protein truncation
(Fig. 7C), suggesting an N-terminal CAD binding site on
WDR73 (veriﬁed by co-immunoprecipitation with WDR73
and CAD deletion constructs; data not shown).
The WDR73:CAD interaction was not dependent upon
phosphorylation of CAD (n = 6) (Fig. 7C), and not dimin-
ished by changing CAD Ser1859 to alanine, which elimin-
ates its site of phosphorylation by p70 S6 kinase via the
mTORC1 pathway (Robitaille et al., 2013) (n = 2)
(Supplementary Fig. 4D). We further determined that
WDR73 interacts with p70 S6 kinase through coimmuno-
precipitation of endogenous p70 S6 kinase by FLAG-
WDR73 fusion proteins (n = 11 for wild-type,
p.Phe296Leufs*26; n = 7 for p.Arg256Profs*18) (Fig. 7D).
To probe the inﬂuence of WDR73 on mTORC1 signalling,
we knocked down endogenous WDR73 in HEK-293FT
and mouse neural progenitor cells and determined that
phosphorylation of ribosomal protein S6 (a p70 S6 kinase
substrate) was reduced without a decrease in S6 protein
abundance (Fig. 7E and Supplementary Fig. 4E).
Relative to FLAG-WDR73 wild-type (n = 7), truncated
NCS WDR73 FLAG fusion proteins consistently co-immu-
noprecipitated substantially more endogenous HSP-70
(n = 5) (Fig. 7A) and HSP-90 (n = 7) from HEK-293T lys-
ates (Fig. 7C), indicating that truncated proteins misfold
and/or require additional chaperoning (Taipale et al.,
2010; Makhnevych and Houry, 2012).
Discussion
We describe a novel truncating frameshift mutation in
WDR73 associated with a severe nephrocerebellar syn-
drome (NCS). NCS ﬁts within the broad and evolving
phenotypic spectrum of Galloway-Mowat syndrome
(OMIM 251300), which is likely genetically heterogenous
in aetiology (Pezzella et al., 2010; Keith et al., 2011;
Ekstrand et al., 2012; Colin et al., 2014). Our neuropatho-
logical ﬁndings of delamination of the lateral geniculate
nucleus, selective loss of cholinergic interneurons in the
striatum and the absence of polymicrogyria and heterotopia
in NCS patients are novel, and extend the pathological
spectrum of Galloway-Mowat syndrome.
We provide the ﬁrst description of the WDR73 interac-
tome, as well as evidence, corroborating a recent report by
Colin et al. (2014), that WDR73 interacts with mitotic
microtubules and is critical for normal cell cycle progres-
sion, proliferation and survival of human ﬁbroblasts, podo-
cytes and neuronal subtypes. The two mutations associated
with NCS we describe delete the sixth WDR73 C-terminal
WD repeat domain and signiﬁcantly alter the ﬁfth, leading
to loss of function, protein instability, and enhanced inter-
actions with - and b-tubulin. In ﬁbroblasts, homozygous
loss of WDR73 function results in decreased cell prolifer-
ation and abnormal cell cycle progression that can be res-
cued with wild-type WDR73 (Fig. 6). Whether the increase
in apoptosis observed by Colin et al. (2014) in patient
ﬁbroblasts homozygous for WDR73 p.Tyr43* is a direct
effect of WDR73 loss of function or a downstream effect of
aborted cell cycle in bi- and multi-nucleated cells remains to
be determined. Indeed, occasional binucleate cells were
observed in post-mortem NCS cerebella (Supplementary
Fig. 1).
Localization of wild-type WDR73 to the mitotic spindle,
where it interacts with tubulin subunits, raises important
questions about how WDR73 inﬂuences the function of
the spindle and centrosome. Most genes linked to decreased
brain size encode centrosomal proteins (e.g. WDR62)
(Nicholas et al., 2010; Yu et al., 2010; Chen et al., 2014)
and dysfunction of the mitotic spindle is a well-established
cause of microcephaly (Gilmore and Walsh, 2013).
Abnormal nuclear morphologies observed in NCS proband
ﬁbroblasts are consistent with cytokinesis failure, indicating
failure of the mitotic spindle (Normand and King, 2010).
Overstabilization of interactions between pathogenic
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Figure 6 Recombinant WDR73-V5 fusion protein rescues cell cycle defect in NCS patient fibroblasts. (A and B) Anti-V5 im-
munofluorescence (green) demonstrates that WDR73 C-terminal V5 fusion protein (WDR73–V5) overexpressed in NCS patient fibroblasts
localizes to the mitotic microtubules (anti--tubulin) during metaphase (A) and telophase (B), rescuing the cell cycle defect in these cells. (C–E)
Overexpression of WDR73 C-terminal V5 fusion protein (WDR73-V5) in HEK-293T cells. Anti-V5 immunofluorescence is in green; anti--
tubulin in red. During pro-metaphase (C) and metaphase (D) recombinant WDR73-V5 colocalizes with -tubulin at the mitotic spindle and aster
microtubules. (E) WDR73-V5 localizes to the spindle poles, the kinetochore microtubules and the midzone microtubules during anaphase. Scale
bars: A–E = 10mm. (F–G) Western blots of recombinant N-terminal FLAG WDR73 fusion proteins (F) and WDR73 C-terminal V5 fusion
proteins (G) overexpressed for 40–48 h in HEK-293T cells. Anti-COX IV was labelled as a protein loading control. The abundance of FLAG-
WDR73 p.Phe296Leufs*26 (F296Lfs*26) was 2.6- to 5.6-fold lower and FLAG-WDR73 p.Arg256Profs*18 (R256Pfs*18) was 1.6- to 6.5-fold lower
than that of FLAG-WDR73 wild-type (wt) across four replicates despite transfection of equivalent amounts of plasmid DNA, suggesting instability
of the truncated proteins.
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WDR73 fragments and tubulins may hinder normal move-
ment of WDR73 along mitotic microtubules, slow spindle
microtuble dynamics (Colin et al., 2014), and/or slow the
large amount of protein and vesicular trafﬁcking along mi-
totic microtubules during cell cycle (Hu et al., 2012;
Agromayor and Martin-Serrano, 2013; Green et al., 2013).
Slow proliferation of NCS ﬁbroblasts might also reﬂect
dysfunction of the mTORC1 signalling pathway. Our data
suggest that WDR73 interacts in a complex with the
mTORC1-regulated p70 S6 kinase and its natural sub-
strate, CAD (Ben-Sahra et al., 2013; Robitaille et al.,
2013). CAD is responsible for de novo pyrimidine synthesis
during S-phase (Ben-Sahra et al., 2013; Robitaille et al.,
2013). Knockdown of Wdr73 in mouse neural progenitor
cells resulted in decreased phosphorylation of ribosomal
protein S6 (the p70 S6 kinase substrate) (Fig. 7 and
Supplementary Fig. 4). Moreover, inactivation of
mTORC1 signalling in Rptor knockout mice results in
Figure 7 WDR73 interacts with a-, b-, and -tubulin, CAD, HSP-70, HSP-90, and p70 S6 kinase. (A) FLAG-WDR73 F296Lfs*26
(38 kDa) overexpressed in HEK-293T cells co-immunoprecipitated (IP) substantially more endogenous - and b-tubulin and HSP-70 than FLAG-
WDR73 wild-type (45 kDa). (B) FLAG-WDR73 wild-type, F296Lfs*26, and R256Pfs*18 each co-immunoprecipitated -tubulin at an abundance
roughly proportional to abundance of the respective WDR73 construct. (C and D) Co-immunoprecipitation of (C) endogenous CAD, phospho-
Ser1859 CAD, HSP-90, and (D) p70 S6 kinase from lysates of HEK-293T cells overexpressing the WDR73 constructs indicated. (E) Lentiviral
transduction of shRNA plasmid constructs A and B targeting WDR73 in HEK-293FT cells successfully knocked down WDR73 and produced a
concomitant decrease in ribosomal protein S6 phosphorylation. GAPDH was labelled as a protein loading control. This immunoblot was labelled
with the same anti-WDR73 antibody (Novus) used for immunoblotting throughout the paper (validating the specificity of the antibody).
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microcephaly associated with reduced neural progenitor cell
proliferation, slowing of neural progenitor cell cycle, and
increased neuroblast apoptosis, as well as proteinuria and
progressive glomerulosclerosis (Godel et al., 2011; Cloetta
et al., 2013). We attempted to rescue reduced proliferation
of NCS ﬁbroblasts with uridine (pyrimidine) supplementa-
tion, but did not observe improvements in cell proliferation
or morphology (data not shown).
Key functions of WDR73 in vivo remain to be deﬁned,
but the consistent and severe NCS phenotype reported here
and by Colin et al. (2014) indicates that WDR73 has spe-
ciﬁc and indispensable roles in generation, proliferation,
and/or viability of cortical neuroblasts, development of
the cerebellar granule cell layer, survival of cholinergic stri-
atal interneurons, central visual pathway development, and
podocyte biology.
Severe cerebellar pathology in NCS most closely resem-
bles classical descriptions of granular layer aplasia (Smeyne
and Goldowitz, 1989; Harding and Copp, 2008). In foetal
mice, a transient external granular layer arises by prolifer-
ation of cells lining the fourth ventricle (Miale and Sidman,
1961). These cells migrate over the external cerebellar sur-
face and continue to proliferate rapidly until a few weeks
after birth. The murine external granular layer disappears
during the third postnatal week, as its cells migrate inward
past Purkinje neurons to form a compact layer of small
granule cell neurons, the internal granular layer (ten
Donkelaar et al., 2003). Weaver mice (Kcnj6 mutation)
have selective and profound depletion of cerebellar granule
cells caused mainly by accelerated cellular senescence
(Smeyne and Goldowitz, 1989; Harkins and Fox, 2002;
Takahashi et al., 2006).
In human cerebellum, intensive cell proliferation occurs
within the external granular layer between the 28th and
34th gestational weeks and is still active by the ﬁfth post-
natal month (Abraham et al., 2001). The mature number of
granule cells will exceed 50 billion, accounting for 75% of
neurons in the human brain. Hypoplasia and degeneration
of cerebellar tissue observed in NCS reﬂects massive aplasia
and/or depletion of this cerebellar granule cell population
and its associated neuropil due to reduced proliferation,
accelerated demise, or both (Harding and Copp, 2008).
This appears to entrain reactive remodelling and loss of
Purkinje neurons, which are markedly dysmorphic, with
‘weeping’ dendritic branches, spiked dendritic asteroid
bodies, somal sprouts, and bulbous ‘torpedo’ swellings of
proximal axons. The presence of somal sprouts on the sur-
face of Purkinje cells was a remarkable ﬁnding in both NCS
brains. These protrusions are only rarely observed in gran-
ule layer aplasia, and have only been reported in Menkes’
disease (OMIM 309400), an X-linked disorder of copper
metabolism (Harding, 2013). Although deep cerebellar
nuclei remain intact in NCS brain, the histopathology sug-
gests a profound disruption of cerebellar feedback to the
nervous system, which must contribute signiﬁcantly to
visual (Voogd et al., 2012; Saglam et al., 2014), sensori-
motor (Volpe, 2009; Manto and Oulad Ben Taib, 2013),
and cognitive (Barton, 2012; Hoche et al., 2014) disabilities
of affected individuals.
Selective depletion of striatal cholinergic interneurons
alters signalling through cortico-basal-thalamic circuits to
produce an array of extrapyramidal movements (i.e. dys-
tonia, chorea, restlessness) (Pisani et al., 2007; Aosaki
et al., 2010; Goldberg et al., 2012). We found further
evidence of selective neuronal vulnerability within lateral
geniculate nuclei, which were depleted of magno- and
parvocellular neurons and devoid of their hexalaminar or-
ganization. We have no way to determine if this reﬂects a
paucity of anterograde trophic signalling from the retinae
to the lateral geniculate nuclei, or if primary neuronal
hypoplasia within the lateral geniculate nuclei or striate
cortex leads to transneuronal, retrograde atrophy of retinal
ganglion cell axons within the optic tracts. Selective injury
to any neuronal population within the central visual system
appears to entrain degeneration of all neural elements
within the pathway (You et al., 2012; Hendrickson et al.,
2013).
Glomerular ﬁndings in NCS are those of classic ster-
oid non-responsive focal segmental glomerulosclerosis
(D’Agati et al., 2011; D’Agati, 2012). Podocyte injury
and depletion is common to all forms of focal segmental
glomerulosclerosis (Barisoni, 2012; D’Agati, 2012) and was
evident on electron micrographs from NCS kidney, which
showed effacement and microvillus remodelling of 80–90%
of podocytes. Morphological and functional changes of
NCS kidney reﬂect an important but as yet poorly under-
stood role of WDR73 in podocyte biology (Colin et al.,
2014). We observed ‘striped ﬁbrosis’ and tubular atrophy
resembling that caused by calcineurin inhibitors, cyclospor-
ine and tacrolimus (Shihab, 1996; Liptak and Ivanyi,
2006). These changes could be non-speciﬁc, but may also
be a clue to underlying signalling mechanisms relevant to
NCS. For example, the mammalian target of rapamycin
(mTOR), a key determinant of human cortical growth
and organization (Orlova and Crino, 2010; Cloetta et al.,
2013; Lim and Crino, 2013; Tsai et al., 2014), also inﬂu-
ences podocyte shape and function (Godel et al., 2011;
Cina et al., 2012; Jeruschke et al., 2013; Muller-Krebs
et al., 2013; Zaza et al., 2014). Recent evidence suggests
an important interaction between mTOR and calcineurin
pathways in renal cell lines (Basu et al., 2011, 2012),
and this could provide new insights into the pathophysi-
ology of NCS.
Although genetic evidence for pathogenicity of WDR73
c.888delT is deﬁnitive, the linked truncating variant in
WHAMM (c.1264_1270delATAAAAG) (NM_00108043
5.2) merits additional investigation. As the phenotypical
outcome of loss of WHAMM function alone is currently
unknown we cannot exclude the possibility that patients
doubly homozygous for WHAMM and WDR73 mutations
may have a modiﬁed phenotype. Further long-term clinical
assessments of these individuals, or the identiﬁcation of
subjects who are homozygous for WHAMM c.1264_1270
delATAAAAG but heterozygous (or wild-type) for
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WDR73, may help to clarify this question. However, our
data, corroborated by recent observations of Colin et al.
(2014), support the assertion that WDR73 loss-of-function
is sufﬁcient to cause NCS on the Galloway-Mowat
spectrum.
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